Dr. Reddy's Laboratories launches Donepezil Hydrochloride Tablets, 23 mg

29 Jul 2013 Evaluate

Dr. Reddy's Laboratories has launched Donepezil Hydrochloride Tablets, 23 mg, a therapeutic equivalent generic version of ARICEPT, 23 mg in the US market on July 26, 2013, following the approval by the United States Food & Drug Administration (USFDA) of the company’s ANDA for Donepezil Hydrochloride Tablets, 23 mg. Dr. Reddy’s Donepezil Hydrochloride Tablets, 23 mg is available in bottle count sizes of 30 and 90.

The ARICEPT, 23 mg brand had US sales of approximately $92.6 million MAT for the most recent twelve months ending in May 2013 according to IMS Health.

Dr Reddy's is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.

Dr. Reddys Lab Share Price

1275.50 24.40 (1.95%)
11-Dec-2025 13:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.45
Dr. Reddys Lab 1275.50
Cipla 1511.40
Zydus Lifesciences 925.70
Lupin 2082.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×